in the 3Q12 results released on 9 nov, these were the next events expected. which one might it be???
Upcoming milestones:
• Announcement of EU site selection for post-marketing trial for the C-Pulse System expected to commence in the fourth quarter of 2012
• Unconditional IDE approval from the FDA expected in the fourth quarter of 2012
• Initiation of pivotal trial planned for the fourth quarter of 2012
- Forums
- ASX - By Stock
- trading halt
in the 3Q12 results released on 9 nov, these were the next...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit